Patient Education

Loneliness is a neuropsychiatric symptom that has been associated with cognitive impairment and dementia. We aimed to investigate whether depressive symptomatology…

ObjectiveIdentification of clinically meaningful subphenotypes of disease progression can enhance the understanding of disease heterogeneity and underlying…

PurposeAccording to a WHO statement, it has been asserted that there is no safe level of alcohol consumption regarding human health. Nevertheless, the relationship…

AbstractThe progressive number of old adults with cognitive impairment worldwide and the lack of effective pharmacologic therapies require the development of non-…

Key PointsQuestionWhat is the safety, tolerability, and efficacy of N-acetylcysteine (NAC) for patients with hereditary cystatin C amyloid angiopathy (HCCAA)?…

AbstractThe amyloid hypothesis has been a leading narrative concerning the pathophysiological foundation of Alzheimer’s and Parkinson’s disease. At the two ends of…

AbstractYears of experience watching our patients progressively decline and die from complications of Alzheimer's disease (AD) has strongly motivated us to provide…

AbstractIntroductionThis prospective observational study of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) undergoing treatment with tafamidis aims at…

BackgroundAmyloidosis is a complex and rare disease requiring specialized, multidisciplinary care to effectively manage its diverse manifestations. Existing…

AbstractIntroduction: Three treatments for Alzheimer's disease have been approved in the United States. Data are lacking on the characteristics of the initial…